Mitchell P. Kopin 13D and 13G filings for Agile Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 06:06 am Sale | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 54,600 6.300% | -14,007 (-20.42%) | Filing |
| 2022-07-11 06:06 am Purchase | 2022-07-01 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 68,607 9.990% | 68,607 (New Position) | Filing |